⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL322524 | 1.00 | — | — | |
| SCHEMBL82889 | 1.00 | — | — | |
| SCHEMBL6525353 | 0.91 | — | — | |
| SCHEMBL387641 | 0.67 | — | — | |
| SCHEMBL477777 | 0.63 | — | — | |
| SCHEMBL3041141 | 0.60 | — | — | |
| SCHEMBL775882 | 0.60 | — | — | |
| SCHEMBL14890300 | 0.60 | — | — | |
| SCHEMBL38170 | 0.56 | — | — | |
| SCHEMBL6359505 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2646 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3976189-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASES | GALAPAGOS NV (BE) | 2024-07-03 | — | — | EP | claimed |
| WO-2024118887-A1 | N-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS WILD TYPE C-KIT KINASE INHIBITORS FOR THE TREATMENT OF URTICARIA | BLUEPRINT MEDICINES CORPORATION (US) | 2024-06-06 | — | — | WO | claimed |
| CN-117903163-A | Fluoroquinolone compound with spiro structure at C7 position and application thereof | 广东工业大学 | 2024-04-19 | — | — | CN | claimed |
| US-20240116910-A1 | Heterocycles as WIP1 Inhibitors | PMV PHARMACEUTICALS, INC. | 2024-04-11 | — | — | US | claimed |
| WO-2024042361-A1 | TYK2 INHIBITORS AND USES THEREOF | SUDO BIOSCIENCES LIMITED (GB) | 2024-02-29 | — | — | WO | claimed |
| US-20230416205-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | TENVIE THERAPEUTICS, INC. | 2023-12-28 | — | — | US | claimed |
| EP-4284797-A1 | PYRAZOLEAMIDE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-12-06 | — | — | EP | claimed |
| US-20230382911-A1 | PYRAZOLEAMIDE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-11-30 | — | — | US | claimed |
| WO-2023227946-A1 | TYK2 INHIBITORS AND USES THEREOF | SUDO BIOSCIENCES LIMITED (GB) | 2023-11-30 | — | — | WO | claimed |
| CN-116867782-A | Pyrazole amide derivative | 豪夫迈·罗氏有限公司 | 2023-10-10 | — | — | CN | claimed |
| EP-0757675-A1 | NOVEL QUINOLONE 5-(N-HETEROSUBSTITUTED AMINO) ANTIMICROBIALS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-12 | — | — | EP | claimed |
| US-5556979-A | ANIMAL FEEDS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-09-17 | — | — | US | claimed |
| EP-0588166-B1 | Antibacterial 7-isoindolinyl-quinolone and naphthyridone derivatives | BAYER AG (DE) | 1996-06-05 | — | — | EP | claimed |
| WO-1995029894-A1 | NOVEL QUINOLONE 5-(N-HETEROSUBSTITUTED AMINO) ANTIMICROBIALS | THE PROCTER & GAMBLE COMPANY (US) | 1995-11-09 | — | — | WO | claimed |
| EP-0666853-A1 | ANTIMICROBIAL 5-HYDRAZINO-QUINOLONE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1995-08-16 | — | — | EP | claimed |
| EP-0434624-B1 | Triazolylsulfonamides | CIBA GEIGY AG (CH) | 1995-02-08 | — | — | EP | claimed |
| WO-1994010163-A1 | ANTIMICROBIAL 5-HYDRAZINO-QUINOLONE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1994-05-11 | — | — | WO | claimed |
| EP-0588166-A2 | Antibacterial 7-isoindolinyl-quinolone and naphthyridone derivatives | BAYER AG (DE) | 1994-03-23 | — | — | EP | claimed |
| US-5217521-A | Preemergence, postemergence herbicides | CIBA-GEIGY CORPORATION (US) | 1993-06-08 | — | — | US | claimed |
| EP-0434624-A1 | Triazolylsulfonamides | CIBA-GEIGY AG (CH) | 1991-06-26 | — | — | EP | claimed |